Online Program Home
  My Program

All Times EDT

Abstract Details

Activity Number: 91 - Section on Physical and Engineering Sciences P.M. Roundtable Discussion
Type: Roundtables
Date/Time: Monday, August 3, 2020 : 12:00 PM to 1:00 PM
Sponsor: Section on Physical and Engineering Sciences
Abstract #309669
Title: Integrating Data Science and Statistics in Pharmaceutical Statistical Engineering and Research
Author(s): Stan Altan* and Brad Evans and Terri Bui and Mark Daniel Ward
Companies: and Pfizer and Merck and Purdue Univ
Keywords: Data Science, Statistics, Interface
Abstract:

Data Science (DS) as a discipline seeks to bring new approaches to further scientific understanding and elucidate essential relationships with an emphasis on “large” datasets. The tools of DS are highly computational and do not follow traditional statistical approaches. In pharmaceutical engineering and research, large datasets are found throughout the drug development process, in both clinical and nonclinical studies. Therefore these represent fertile areas for the application of DS approaches, related to AI, ML and others. Standard traditional statistical approaches are giving way to these newer methods, and consequently important questions arise regarding the respective roles of Statistics and DS. This round table seeks to bring together individuals from both disciplines to discuss the following questions among others : 1. What is DS, how does it differ from Statistics. 2. What are the appropriate roles of DS and Statistics in furthering better understanding of pharmaceutical scientific and engineering studies. 3. What are the hurdles preventing the Pharmaceutical Sciences from utilizing data science tools? 4. How does one build a business case for DS approaches.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2020 program